NVCT
Nuvectis Pharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$210.08M
P/E Ratio
—
EPS
$-1.32
Beta
-0.21
52W High
$11.52
52W Low
$5.55
50-Day MA
$8.53
200-Day MA
$7.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nuvectis Pharma Inc
Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -188.00% |
| Return on Assets | -68.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.72 |
| Price-to-Book | 10.82 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -7.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $26.49M |
| Float | $15.49M |
| % Insiders | 41.59% |
| % Institutions | 17.20% |
Data last updated: 4/9/2026